Understand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.

Learn why now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.

Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.

Drawing inspiration from real-world instances within the pharmaceutical and medical device sectors, watch as industry experts unravel the pivotal role of eConsent in optimizing modern clinical trials.

It’s apparent to those who have used it that the “e” in eConsent could stand for much more than 'electronic'. Duke’s new research shows why participants prefer an eConsent experience bolstered with videos, media, questions, and more.

This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

Understand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.

Get an overview of SISCAPA's utilization of eTechnologies, specifically ePRO, and how their partnership with CDS accurately demonstrates the improvement of data collection and analysis in the biotechnology industry.

Dive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.